A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
Kael Wherry, PhD
Advertisement
Articles by Kael Wherry, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
2
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
3
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
4
The Next Frontier in Hepatitis B Functional and Virologic Cure
5